Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Immunosuppressive Agents"" wg kryterium: Temat


Tytuł :
[Vaccination against SARS-CoV-2 in patients with multiple sclerosis].
Autorzy :
Costa Frossard-França L; Hospital Universitario Ramón y Cajal, Madrid, España.
García-Domínguez JM; Hospital Universitario Gregorio Marañón, Madrid, España.
Moreno-Torres I; Hospital Universitario Fundación Jiménez Díaz, Madrid, España.
Fortún J; Hospital Universitario Ramón y Cajal, 28034 Madrid, España.
Villar LM; Hospital Universitario Ramón y Cajal, Madrid, España.
Meca-Lallana V; Hospital Universitario La Princesa, Madrid, España.
Pokaż więcej
Transliterated Title :
Vacunación frente al SARS-CoV-2 en pacientes con esclerosis múltiple.
Źródło :
Revista de neurologia [Rev Neurol] 2021 Apr 01; Vol. 72 (7), pp. 250-260.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Vaccines*/administration & dosage
COVID-19 Vaccines*/adverse effects
COVID-19 Vaccines*/immunology
Vaccination*/adverse effects
COVID-19/*prevention & control
Immunosuppressive Agents/*adverse effects
Multiple Sclerosis/*immunology
SARS-CoV-2/*immunology
Antibodies, Viral/biosynthesis ; Antibody Formation/drug effects ; COVID-19/immunology ; Communicable Disease Control/methods ; Humans ; Immunization Schedule ; Immunocompromised Host ; Immunogenicity, Vaccine ; Immunosuppressive Agents/pharmacology ; Immunosuppressive Agents/therapeutic use ; Influenza Vaccines/administration & dosage ; Masks ; Multiple Sclerosis/drug therapy
Czasopismo naukowe
Tytuł :
COVID-19 and influenza A coinfection: a matter of principle.
Autorzy :
Lozano-Parras MA; Servicio de Medicina Interna. Hospital Clínico San Carlos, Madrid, España. Electronic address: .
Amann-Arévalo M; Servicio de Medicina Interna. Hospital Clínico San Carlos, Madrid, España.
Ciller-Martínez M; Servicio de Medicina Interna. Hospital Clínico San Carlos, Madrid, España.
Culebras-López E; Servicio de Microbiología. Hospital Clínico San Carlos, Madrid, España.
Pokaż więcej
Transliterated Title :
Coinfección por COVID-19 y gripe A: una cuestión de principios.
Źródło :
Enfermedades infecciosas y microbiologia clinica [Enferm Infecc Microbiol Clin] 2021 Apr; Vol. 39 (4), pp. 214-215. Date of Electronic Publication: 2020 Jul 16.
Typ publikacji :
Case Reports
MeSH Terms :
Adrenal Cortex Hormones/*therapeutic use
Anti-Inflammatory Agents/*therapeutic use
COVID-19/*complications
Coinfection/*virology
Immunosuppressive Agents/*therapeutic use
Influenza A virus/*isolation & purification
Influenza, Human/*complications
Pneumonia, Viral/*drug therapy
Adrenal Cortex Hormones/adverse effects ; Adrenal Cortex Hormones/pharmacology ; Anti-Inflammatory Agents/adverse effects ; Anti-Inflammatory Agents/pharmacology ; COVID-19/diagnostic imaging ; COVID-19/drug therapy ; COVID-19/virology ; COVID-19 Nucleic Acid Testing ; Contraindications, Drug ; Female ; Humans ; Immunosuppressive Agents/adverse effects ; Immunosuppressive Agents/pharmacology ; Influenza, Human/drug therapy ; Influenza, Human/virology ; Middle Aged ; Nasopharynx/virology ; Pneumonia, Viral/diagnostic imaging ; Pneumonia, Viral/etiology ; Remission Induction ; SARS-CoV-2/drug effects ; SARS-CoV-2/isolation & purification
Raport
Tytuł :
Baicalin suppresses type 2 immunity through breaking off the interplay between mast cell and airway epithelial cell.
Autorzy :
Yoshida K; Division of Otorhinolaryngology Head and Neck Surgery, Department of Sensory and Locomotor Medicine, University of Fukui, 23 Shimoaizuki, Matsuoka, Yoshida, Fukui, Japan.
Takabayashi T; Division of Otorhinolaryngology Head and Neck Surgery, Department of Sensory and Locomotor Medicine, University of Fukui, 23 Shimoaizuki, Matsuoka, Yoshida, Fukui, Japan. Electronic address: .
Kaneko A; Tsumura Kampo Research Laboratories, Tsumura & Co., 3586 Yoshiwara, Ami- Machi, Inashiki-gun, Ibaraki, Japan.
Takiyama M; Tsumura Kampo Research Laboratories, Tsumura & Co., 3586 Yoshiwara, Ami- Machi, Inashiki-gun, Ibaraki, Japan.
Sakashita M; Division of Otorhinolaryngology Head and Neck Surgery, Department of Sensory and Locomotor Medicine, University of Fukui, 23 Shimoaizuki, Matsuoka, Yoshida, Fukui, Japan.
Imoto Y; Division of Otorhinolaryngology Head and Neck Surgery, Department of Sensory and Locomotor Medicine, University of Fukui, 23 Shimoaizuki, Matsuoka, Yoshida, Fukui, Japan.
Kato Y; Division of Otorhinolaryngology Head and Neck Surgery, Department of Sensory and Locomotor Medicine, University of Fukui, 23 Shimoaizuki, Matsuoka, Yoshida, Fukui, Japan.
Narita N; Division of Otorhinolaryngology Head and Neck Surgery, Department of Sensory and Locomotor Medicine, University of Fukui, 23 Shimoaizuki, Matsuoka, Yoshida, Fukui, Japan.
Fujieda S; Division of Otorhinolaryngology Head and Neck Surgery, Department of Sensory and Locomotor Medicine, University of Fukui, 23 Shimoaizuki, Matsuoka, Yoshida, Fukui, Japan.
Pokaż więcej
Źródło :
Journal of ethnopharmacology [J Ethnopharmacol] 2021 Mar 01; Vol. 267, pp. 113492. Date of Electronic Publication: 2020 Oct 19.
Typ publikacji :
Journal Article
MeSH Terms :
Bronchi/*drug effects
Cell Communication/*drug effects
Flavonoids/*pharmacology
Immunosuppressive Agents/*pharmacology
Mast Cells/*drug effects
Animals ; Bronchi/cytology ; Bronchi/immunology ; Bronchi/metabolism ; Cells, Cultured ; Epithelial Cells/drug effects ; Epithelial Cells/immunology ; Epithelial Cells/metabolism ; Flavonoids/blood ; Flavonoids/pharmacokinetics ; Gene Expression Regulation ; Humans ; Immunosuppressive Agents/blood ; Immunosuppressive Agents/pharmacokinetics ; Interleukin-33/genetics ; Interleukin-33/metabolism ; Interleukin-5/genetics ; Interleukin-5/metabolism ; Male ; Mast Cells/immunology ; Mast Cells/metabolism ; Rats, Sprague-Dawley ; Signal Transduction ; Tryptases/genetics ; Tryptases/metabolism
Czasopismo naukowe
Tytuł :
Efficacy and safety of immunosuppressive therapies in the treatment of high-risk IgA nephropathy: A network meta-analysis.
Autorzy :
Liu T; China Academy of Chinese Medical Sciences, Guang'anmen Hospital, Beijing, China.
Wang Y
Mao H
Yang L
Zhan Y
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Feb 26; Vol. 100 (8), pp. e24541.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Glomerulonephritis, IGA/*drug therapy
Immunosuppressive Agents/*therapeutic use
Adrenal Cortex Hormones/therapeutic use ; Cyclophosphamide/therapeutic use ; Cyclosporine/therapeutic use ; Drug Therapy, Combination ; Glomerular Filtration Rate ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Mycophenolic Acid/therapeutic use ; Network Meta-Analysis ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis: A Phase 2 Randomized Control Trial.
Autorzy :
Bril V; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium. .
Benatar M; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Andersen H; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Vissing J; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Brock M; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Greve B; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Kiessling P; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Woltering F; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Griffin L; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Van den Bergh P; From Toronto General Hospital (V.B.), University Health Network, University of Toronto, Canada; Department of Neurology (M. Benatar), Miller School of Medicine, University of Miami, FL; Department of Neurology (H.A.), Aarhus University Hospital; Department of Neurology, Rigshospitalet (J.V.), University of Copenhagen, Denmark; UCB Pharma (M. Brock), Raleigh, NC; UCB Pharma (B.G., P.K., F.W.), Monheim-am-Rhein, Germany; iMed Communications (L.G.), Macclesfield, UK; and Neuromuscular Reference Centre, Department of Neurology (P.V.d.B.), University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.
Pokaż więcej
Corporate Authors :
MG0002 Investigators
Źródło :
Neurology [Neurology] 2021 Feb 09; Vol. 96 (6), pp. e853-e865. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Outcome Assessment, Health Care*
Antibodies, Monoclonal, Humanized/*pharmacology
Immunosuppressive Agents/*pharmacology
Myasthenia Gravis/*drug therapy
Adult ; Aged ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/adverse effects ; Double-Blind Method ; Female ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Does interval time between liver transplant and COVID-19 infection make the difference?
Autorzy :
Buscemi V; Department of General Surgery and Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy. Electronic address: .
De Carlis R; Department of General Surgery and Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Lauterio A; Department of General Surgery and Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Merli M; Department of Infectious Disease, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Puoti M; Department of Infectious Disease, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
De Carlis L; Department of General Surgery and Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Pokaż więcej
Źródło :
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2021 Feb; Vol. 53 (2), pp. 169-170. Date of Electronic Publication: 2020 Aug 25.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
COVID-19*/complications
COVID-19*/immunology
COVID-19*/therapy
Immunosuppressive Agents*/immunology
Immunosuppressive Agents*/therapeutic use
Liver Transplantation*/adverse effects
Liver Transplantation*/methods
Antiviral Agents/*therapeutic use
Carcinoma, Hepatocellular/*surgery
Immunocompromised Host/*immunology
Antiviral Agents/classification ; Carcinoma, Hepatocellular/pathology ; Female ; Humans ; Liver Neoplasms/pathology ; Liver Neoplasms/surgery ; Middle Aged ; SARS-CoV-2/isolation & purification ; Time ; Treatment Outcome
Raport
Tytuł :
The Clinical Conundrum of Cannabis: Current Practices and Recommendations for Transplant Clinicians: An Opinion of the Immunology/Transplantation PRN of the American College of Clinical Pharmacy.
Autorzy :
Melaragno JI; Department of Pharmacy, University of Rochester Medical Center, Rochester, NY.
Bowman LJ; Department of Pharmacy, Tampa General Hospital, Tampa, FL.
Park JM; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI.
Lourenco LM; Department of Pharmacy Services, University of Chicago Medicine, Chicago, IL.
Doligalski CT; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC.
Brady BL; Department of Pharmacy, Indiana University Health University Hospital, Indianapolis, IN.
Descourouez JL; Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison, WI.
Chandran MM; Department of Pharmacy, Children's Hospital Colorado, Aurora, CO.
Nickels MW; Department of Psychiatry, University of Rochester Medical Center, Rochester, NY.
Page RL 2nd; Department of Clinical Pharmacy, University of Colorado, Aurora, CO.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2021 Feb 01; Vol. 105 (2), pp. 291-299.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Organ Transplantation*/adverse effects
Organ Transplantation*/legislation & jurisprudence
Immunosuppressive Agents/*pharmacokinetics
Marijuana Abuse/*complications
Marijuana Smoking/*adverse effects
Medical Marijuana/*adverse effects
Clinical Decision-Making ; Drug Interactions ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Marijuana Abuse/immunology ; Marijuana Smoking/immunology ; Marijuana Smoking/legislation & jurisprudence ; Policy Making ; Risk Assessment ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Rituximab and glatiramer acetate in secondary progressive multiple sclerosis: A randomized clinical trial.
Autorzy :
Cheshmavar M; Isfahan Neurosciences Research Center, Alzahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Mirmosayyeb O; Isfahan Neurosciences Research Center, Alzahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Badihian N; Isfahan Neurosciences Research Center, Alzahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.; Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
Badihian S; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Shaygannejad V; Isfahan Neurosciences Research Center, Alzahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Pokaż więcej
Źródło :
Acta neurologica Scandinavica [Acta Neurol Scand] 2021 Feb; Vol. 143 (2), pp. 178-187. Date of Electronic Publication: 2020 Oct 27.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Glatiramer Acetate/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Multiple Sclerosis, Chronic Progressive/*drug therapy
Rituximab/*therapeutic use
Adult ; Female ; Glatiramer Acetate/administration & dosage ; Glatiramer Acetate/adverse effects ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Male ; Middle Aged ; Rituximab/administration & dosage ; Rituximab/adverse effects
Czasopismo naukowe
Tytuł :
Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients.
Autorzy :
González-Barca E; Lymphoma Unit, Hematology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, Av. Gran Via 199-203, 08908, Hospitalet de Llobregat, Barcelona, Spain. .
Capote FJ; Hematology, Hospital Puerta del Mar, Cádiz, Spain.
Gómez-Codina J; Onclology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Panizo C; Hematology, Clínica Universitaria de Navarra, Navarra, Spain.
Salar A; Hematology, Hospital del Mar, Barcelona, Spain.
Sancho JM; Hematology, Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain.
López A; Hematology, Hospital de la Vall d'Hebron, Barcelona, Spain.
Briones J; Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
Muñoz A; Oncology, Hospital Gregorio Marañón, Madrid, Spain.
Encuentra M; Clinical Trial Unit, Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, Barcelona, Spain.
Mercadal S; Lymphoma Unit, Hematology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, Av. Gran Via 199-203, 08908, Hospitalet de Llobregat, Barcelona, Spain.
Domingo-Domenech E; Lymphoma Unit, Hematology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, Av. Gran Via 199-203, 08908, Hospitalet de Llobregat, Barcelona, Spain.
de Sevilla AF; Lymphoma Unit, Hematology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, Av. Gran Via 199-203, 08908, Hospitalet de Llobregat, Barcelona, Spain.
Pokaż więcej
Corporate Authors :
GELTAMO (Spanish Lymphoma Group) and GOTEL (Group of Oncology for Therapy and Study of Lymphomas)
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 1023-1029. Date of Electronic Publication: 2020 May 04.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Pragmatic Clinical Trial
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Lymphoproliferative Disorders/*drug therapy
Rituximab/*therapeutic use
Adult ; Aged ; Antineoplastic Agents/administration & dosage ; B-Lymphocytes/pathology ; Disease Progression ; Disease-Free Survival ; Epstein-Barr Virus Infections ; Female ; Follow-Up Studies ; Humans ; Immunosuppressive Agents/administration & dosage ; Kaplan-Meier Estimate ; Lymphoproliferative Disorders/etiology ; Male ; Middle Aged ; Organ Transplantation/adverse effects ; Prospective Studies ; Remission Induction ; Rituximab/administration & dosage ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series.
Autorzy :
Martynova A; Jane Anne Nohl Division of Hematology, Keck-USC School of Medicine, Los Angeles, CA, USA.
Chiu V; Jane Anne Nohl Division of Hematology, Keck-USC School of Medicine, Los Angeles, CA, USA.
Mert M; Jane Anne Nohl Division of Hematology, Keck-USC School of Medicine, Los Angeles, CA, USA.
Hermel D; Jane Anne Nohl Division of Hematology, Keck-USC School of Medicine, Los Angeles, CA, USA.
Weitz IC; Jane Anne Nohl Division of Hematology, Keck-USC School of Medicine, Los Angeles, CA, USA. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 933-939. Date of Electronic Publication: 2021 Jan 09.
Typ publikacji :
Journal Article
MeSH Terms :
Anemia, Aplastic/*drug therapy
Benzoates/*therapeutic use
Hydrazines/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Pyrazoles/*therapeutic use
Tacrolimus/*therapeutic use
Adult ; Aged ; Antilymphocyte Serum/adverse effects ; Antilymphocyte Serum/therapeutic use ; Benzoates/adverse effects ; Cyclosporine/adverse effects ; Cyclosporine/therapeutic use ; Drug Eruptions/etiology ; Female ; Gingival Hypertrophy/chemically induced ; Hirsutism/chemically induced ; Humans ; Hydrazines/adverse effects ; Immunosuppressive Agents/adverse effects ; Male ; Middle Aged ; Pyrazoles/adverse effects ; Retrospective Studies ; Tacrolimus/adverse effects
Czasopismo naukowe
Tytuł :
Effect of Calcineurin Inhibitors and Mammalian Target of Rapamycin Inhibitors on the Course of COVID-19 in Kidney Transplant Recipients.
Autorzy :
Hasbal NB; Clinic of Nephrology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Turgut D; Department of Nephrology, Baskent University School of Medicine, Ankara, Turkey.
Gok Oguz E; Department of Nephrology, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.
Ulu S; Department of Nephrology, Afyonkarahisar Health Sciences University School of Medicine, Afyonkarahisar, Turkey.
Gungor O; Department of Nephrology, Kahramanmaras Sutcu Imam University School of Medicine, Kahramanmaras, Turkey.
Pokaż więcej
Źródło :
Annals of transplantation [Ann Transplant] 2021 Mar 12; Vol. 26, pp. e929279. Date of Electronic Publication: 2021 Mar 12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Kidney Transplantation*
COVID-19/*immunology
Calcineurin Inhibitors/*therapeutic use
Graft Rejection/*prevention & control
Immunosuppressive Agents/*therapeutic use
Postoperative Complications/*immunology
Protein Kinase Inhibitors/*therapeutic use
Adaptive Immunity/drug effects ; COVID-19/diagnosis ; Calcineurin Inhibitors/pharmacology ; Cytokine Release Syndrome/immunology ; Cytokine Release Syndrome/prevention & control ; Cytokine Release Syndrome/virology ; Graft Rejection/immunology ; Humans ; Immunity, Innate/drug effects ; Immunocompromised Host ; Immunosuppressive Agents/pharmacology ; Oxidative Stress/drug effects ; Oxidative Stress/immunology ; Postoperative Complications/diagnosis ; Postoperative Complications/virology ; Protein Kinase Inhibitors/pharmacology ; TOR Serine-Threonine Kinases/antagonists & inhibitors
Czasopismo naukowe
Tytuł :
Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic.
Autorzy :
Noreen S; Department of Pharmaceutics, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, 63100, Punjab, Pakistan. Electronic address: .
Maqbool I; Department of Pharmaceutics, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, 63100, Punjab, Pakistan. Electronic address: .
Madni A; Department of Pharmaceutics, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, 63100, Punjab, Pakistan. Electronic address: .
Pokaż więcej
Źródło :
European journal of pharmacology [Eur J Pharmacol] 2021 Mar 05; Vol. 894, pp. 173854. Date of Electronic Publication: 2021 Jan 08.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Pandemics*
Anti-Inflammatory Agents/*therapeutic use
COVID-19/*drug therapy
Dexamethasone/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Anti-Inflammatory Agents/adverse effects ; COVID-19/complications ; COVID-19/mortality ; Dexamethasone/adverse effects ; Humans ; Immunosuppressive Agents/adverse effects ; Respiratory Distress Syndrome/drug therapy ; Respiratory Distress Syndrome/etiology
Czasopismo naukowe
Tytuł :
Impact of disease-modifying drugs on the severity of  COVID-19 infection in multiple sclerosis patients.
Autorzy :
Rostami Mansoor S; Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Ghasemi-Kasman M; Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.; Neuroscience Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Pokaż więcej
Źródło :
Journal of medical virology [J Med Virol] 2021 Mar; Vol. 93 (3), pp. 1314-1319. Date of Electronic Publication: 2020 Oct 30.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19/*pathology
Immunologic Factors/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Multiple Sclerosis/*drug therapy
Animals ; COVID-19/immunology ; Humans ; Immunologic Factors/immunology ; Immunosuppressive Agents/immunology ; Multiple Sclerosis/immunology ; Pandemics/prevention & control ; SARS-CoV-2/immunology ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Low-dose 2-deoxy glucose stabilises tolerogenic dendritic cells and generates potent in vivo immunosuppressive effects.
Autorzy :
Christofi M; Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, Foresterhill, University of Aberdeen, Aberdeen, AB25 2ZD, Scotland, UK.
Le Sommer S; Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, Foresterhill, University of Aberdeen, Aberdeen, AB25 2ZD, Scotland, UK.
Mölzer C; Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, Foresterhill, University of Aberdeen, Aberdeen, AB25 2ZD, Scotland, UK. .
Klaska IP; Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, Foresterhill, University of Aberdeen, Aberdeen, AB25 2ZD, Scotland, UK.
Kuffova L; Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, Foresterhill, University of Aberdeen, Aberdeen, AB25 2ZD, Scotland, UK.; Eye Clinic, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK.
Forrester JV; Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, Foresterhill, University of Aberdeen, Aberdeen, AB25 2ZD, Scotland, UK. .; Ocular Immunology Program, Centre for Ophthalmology and Visual Science, The University of Western Australia, Perth, WA, Australia. .; Centre for Experimental Immunology, Lions Eye Institute, Nedlands, WA, Australia. .
Pokaż więcej
Źródło :
Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2021 Mar; Vol. 78 (6), pp. 2857-2876. Date of Electronic Publication: 2020 Oct 19.
Typ publikacji :
Journal Article
MeSH Terms :
Dendritic Cells/*metabolism
Deoxyglucose/*pharmacology
Glycolysis/*drug effects
Immunosuppressive Agents/*pharmacology
Animals ; Antigens, Bacterial/immunology ; Autoimmune Diseases/drug therapy ; B7-2 Antigen/metabolism ; Bone Marrow Cells/cytology ; CD4-Positive T-Lymphocytes/cytology ; CD4-Positive T-Lymphocytes/metabolism ; Cell Proliferation/drug effects ; Dendritic Cells/cytology ; Dendritic Cells/drug effects ; Deoxyglucose/therapeutic use ; Histocompatibility Antigens Class II/metabolism ; Immunosuppressive Agents/therapeutic use ; Interleukin-10/metabolism ; Lactic Acid/metabolism ; Mice ; Mice, Inbred C57BL ; Oxidative Phosphorylation/drug effects ; Phosphatidylinositol 3-Kinases/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Signal Transduction/drug effects
Czasopismo naukowe
Tytuł :
Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease.
Autorzy :
Scharrer S; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna.
Kutschera M; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna.
Weseslindtner L; Department of Virology, Medical University of Vienna, Vienna, Austria.
Primas C; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna.
Vogelsang H; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna.
Pokaż więcej
Źródło :
European journal of gastroenterology & hepatology [Eur J Gastroenterol Hepatol] 2021 Mar 01; Vol. 33 (3), pp. 443-447.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Immunity, Humoral*
Immunocompromised Host*
Antibodies, Viral/*blood
COVID-19/*immunology
Colitis, Ulcerative/*drug therapy
Crohn Disease/*drug therapy
Immunosuppressive Agents/*administration & dosage
SARS-CoV-2/*immunology
Adult ; Aged ; Biomarkers/blood ; COVID-19/blood ; COVID-19/diagnosis ; COVID-19/virology ; COVID-19 Serological Testing ; Colitis, Ulcerative/diagnosis ; Colitis, Ulcerative/immunology ; Crohn Disease/diagnosis ; Crohn Disease/immunology ; Drug Administration Schedule ; Female ; Host-Pathogen Interactions ; Humans ; Immunosuppressive Agents/adverse effects ; Male ; Middle Aged ; Retrospective Studies ; Time Factors ; Young Adult
Czasopismo naukowe
Tytuł :
Belimumab for systemic lupus erythematosus.
Autorzy :
Singh JA; Department of Medicine, Birmingham VA Medical Center, Birmingham, AL, USA.
Shah NP; Department of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA.
Mudano AS; Department of Medicine - Rheumatology, University of Alabama at Birmingham, Birmingham, USA.
Pokaż więcej
Źródło :
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2021 Feb 25; Vol. 2. Cochrane AN: CD010668. Date of Electronic Publication: 2021 Feb 25.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Antibodies, Monoclonal, Humanized/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Lupus Erythematosus, Systemic/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/adverse effects ; Bias ; Female ; Glucocorticoids/therapeutic use ; Humans ; Immunosuppressive Agents/adverse effects ; Lupus Erythematosus, Systemic/mortality ; Male ; Middle Aged ; Placebos/therapeutic use ; Quality of Life ; Randomized Controlled Trials as Topic ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Negative affect and self-agency's association with immunosuppressant adherence in organ transplant: A meta-analysis.
Autorzy :
Demian MN; Department of Psychology.
Thornton AE; Department of Psychology.
Shapiro RJ; Faculty of Medicine.
Loken Thornton W; Department of Psychology.
Pokaż więcej
Źródło :
Health psychology : official journal of the Division of Health Psychology, American Psychological Association [Health Psychol] 2021 Feb; Vol. 40 (2), pp. 89-103. Date of Electronic Publication: 2020 Dec 03.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Depression/*psychology
Immunosuppressive Agents/*therapeutic use
Organ Transplantation/*psychology
Adult ; Female ; Humans ; Immunosuppressive Agents/pharmacology ; Male ; Medication Adherence/psychology ; Middle Aged ; Prevalence
Czasopismo naukowe
Tytuł :
Treatment Satisfaction With and Adherence to Disease-Modifying Antirheumatic Drugs in Adult Patients With Juvenile Idiopathic Arthritis.
Autorzy :
Tollisen A; Oslo University Hospital, Rikshospitalet, Unger-Vetlesens Institute, Lovisenberg Diaconal Hospital, and University of Oslo, Oslo, Norway.
Flatø B; Oslo University Hospital, Rikshospitalet and University of Oslo, Oslo, Norway.
Selvaag AM; Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Aasland A; Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Ingebrigtsen T; Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Sagen J; Children and Youth Rheumatology Association, Oslo, Norway.
Lerdal A; Lovisenberg Diaconal Hospital and University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło :
Arthritis care & research [Arthritis Care Res (Hoboken)] 2021 Feb; Vol. 73 (2), pp. 221-231.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Medication Adherence*
Patient Satisfaction*
Antirheumatic Agents/*therapeutic use
Arthritis, Juvenile/*drug therapy
Immunosuppressive Agents/*therapeutic use
Methotrexate/*therapeutic use
Adult ; Antirheumatic Agents/adverse effects ; Arthritis, Juvenile/diagnosis ; Drug Therapy, Combination ; Female ; Health Status ; Humans ; Immunosuppressive Agents/adverse effects ; Longitudinal Studies ; Male ; Methotrexate/adverse effects ; Prospective Studies ; Quality of Life ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes.
Autorzy :
Jackson KR; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Long J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Motter J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Bowring MG; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Chen J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Waldram MM; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Orandi BJ; Department of Surgery, University of Alabama, Birmingham, AL.
Montgomery RA; The NYU Transplant Institute, New York University Langone Medical Center, New York, NY.
Stegall MD; Department of Surgery, Mayo Clinic, Rochester, MN.
Jordan SC; Department of Medicine, Cedars-Sinai Comprehensive Transplant Center, Los Angeles, CA.
Benedetti E; Department of Surgery, University of Illinois-Chicago, Chicago, IL.
Dunn TB; Department of Surgery, University of Pennsylvania, Philadelphia, PA.
Ratner LE; Department of Surgery, Columbia University Medical Center, New York, NY.
Kapur S; Department of Surgery, New York Presbyterian/Weill Cornell Medical Center, New York, NY.
Pelletier RP; Department of Surgery, Robert Wood Johnson University Hospital, New Brunswick, NJ.
Roberts JP; Department of Surgery, University of California-San Francisco, San Francisco, CA.
Melcher ML; Department of Surgery, Stanford University, Palo Alto, CA.
Singh P; Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA.
Sudan DL; Department of Surgery, Duke University Medical Center, Durham, NC.
Posner MP; Department of Surgery, Virginia Commonwealth University, Richmond, VA.
El-Amm JM; Integris Baptist Medical Center, Transplant Division, Oklahoma City, OK.
Shapiro R; Recanti Miller Transplantation Institute, Mount Sinai Hospital, New York, NY.
Cooper M; Medstar Georgetown Transplant Institute, Washington, DC.
Verbesey JE; Medstar Georgetown Transplant Institute, Washington, DC.
Lipkowitz GS; Department of Surgery, Baystate Medical Center Springfield, MA.
Rees MA; Department of Urology, University of Toledo Medical Center, Toledo, OH.
Marsh CL; Department of Surgery, Scripps Clinic and Green Hospital, La Jolla, CA.
Sankari BR; Department of Urology, Cleveland Clinic, Cleveland, OH.
Gerber DA; Department of Surgery, University of North Carolina School of Medicine, Chapel Hill, NC.
Wellen J; Department of Surgery, Barnes-Jewish Hospital, St. Louis, MO.
Bozorgzadeh A; Department of Surgery, University of Massachusetts Memorial Medical Center, Worcester, MA.
Gaber AO; Department of Surgery, Houston Methodist Hospital, Houston, TX.
Heher E; Department of Medicine, Massachusetts General Hospital, Boston, MA.
Weng FL; Renal and Pancreas Transplant Division, Saint Barnabas Medical Center, Livingston, NJ.
Djamali A; Department of Medicine, University of Wisconsin, Madison, WI.
Helderman JH; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Concepcion BP; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Brayman KL; Department of Surgery, University of Virginia, Charlottesville, VA.
Oberholzer J; Department of Surgery, University of Virginia, Charlottesville, VA.
Kozlowski T; Department of Surgery, University of Florida, Gainesville, FL.
Covarrubias K; Department of Surgery, University of California San Diego, San Diego, CA.
Desai N; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Massie AB; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Segev DL; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD.; Scientific Registry of Transplant Recipients, Minneapolis, MN.
Garonzik-Wang J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2021 Feb 01; Vol. 105 (2), pp. 436-442.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Healthcare Disparities*
Histocompatibility*
Kidney Transplantation*/adverse effects
Kidney Transplantation*/mortality
Living Donors*
Practice Patterns, Physicians'*
Graft Rejection/*prevention & control
Graft Survival/*drug effects
HLA Antigens/*immunology
Immunosuppressive Agents/*therapeutic use
Isoantibodies/*blood
Adult ; Female ; Graft Rejection/blood ; Graft Rejection/immunology ; Graft Rejection/mortality ; Humans ; Immunosuppressive Agents/adverse effects ; Male ; Middle Aged ; Quality Indicators, Health Care ; Registries ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome ; United States
Czasopismo naukowe
Tytuł :
COVID-19, liver transplant, and immunosuppression: Allies or foes?
Autorzy :
Parente A; Liver Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.; Department of Hepatobiliary Surgery and Transplant Unit, Tor Vergata University of Rome, Rome, Italy.
Manzia TM; Department of Hepatobiliary Surgery and Transplant Unit, Tor Vergata University of Rome, Rome, Italy.
Angelico R; Department of Hepatobiliary Surgery and Transplant Unit, Tor Vergata University of Rome, Rome, Italy.
Tirotta F; Liver Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.
Muiesan P; Liver Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.
Tisone G; Department of Hepatobiliary Surgery and Transplant Unit, Tor Vergata University of Rome, Rome, Italy.
Framarino Dei Malatesta M; Department of Gynecological, Obstetrical, and Urological Sciences, Policlinico Umberto I, University Sapienza of Rome, Rome, Italy.
Pokaż więcej
Źródło :
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2021 Feb; Vol. 23 (1), pp. e13417. Date of Electronic Publication: 2020 Jul 31.
Typ publikacji :
Journal Article
MeSH Terms :
Immunocompromised Host*
Liver Transplantation*
SARS-CoV-2*
Transplant Recipients*
COVID-19/*pathology
Immunosuppressive Agents/*administration & dosage
Adolescent ; Adult ; Child ; Female ; Graft Rejection ; Humans ; Immunosuppressive Agents/therapeutic use ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies